What does PharmaRoth Labs, Inc. do?

PharmaRoth Labs, Inc. (ROTH) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is ROTH's market cap?

PharmaRoth Labs, Inc. (ROTH) has a market capitalization of approximately $3,512, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does ROTH pay a dividend?

No — PharmaRoth Labs, Inc. (ROTH) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

PharmaRoth Labs, Inc. (ROTH) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

ROTH

PharmaRoth Labs, Inc.

OTC·Medical, Pharmaceuticals · Healthcare

$0.00$0.00+0.00%

Market cap$3.51K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−90.00%CAGR −36.97%

Select date range

FromTo

Dec 11, 2008Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

ROTH does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue—

Net Income—

Net Margin—

Operating Cash Flow−$24.67K

Capital Expenditures$7.00

Free Cash Flow−$24.68K

Return on Equity—

Return on Invested Capital0.0%

Net Debt—

Income Statement Flow

PRO

See exactly how ROTH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ROTH and 80,000+ other tickers.

About PharmaRoth Labs, Inc.

PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.

CEO: Luis Manuel Ornelas Lopez
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: OTC
Employees: 0
Website: www.pharmaroth.com

Peers

Peers Tab

DECN

Decision Diagnostics Corp.

Sonomax Technologies Inc

Cap

$38.1K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About ROTH

What does PharmaRoth Labs, Inc. do?: PharmaRoth Labs, Inc. (ROTH) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is ROTH's market cap?: PharmaRoth Labs, Inc. (ROTH) has a market capitalization of approximately $3,512, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does ROTH pay a dividend?: No — PharmaRoth Labs, Inc. (ROTH) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is ROTH profitable?: PharmaRoth Labs, Inc. (ROTH) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.